How to Choose the Best Tirzepatide Company in the UK

Step 1, Confirm the pharmacy is GPhC-registered and the prescribers are qualified

The GPhC (General Pharmaceutical Council) registers all UK pharmacies, and their public register is free to search at pharmacyregulation.org/registers. Type the pharmacy's name or registration number and you will see, in a few seconds, whether it holds a valid premises registration. If a company dispensing tirzepatide is not on that list, stop there.

Beyond premises registration, look at prescribing. Tirzepatide requires a prescription from a qualified Independent Prescriber or a prescribing pharmacist. Some services route consultations through automated questionnaires with a clinician ticking boxes at speed; others have a named prescriber who genuinely reads each submission. Ask, before you commit, who will review your form and how, it changes the quality of care you receive if something needs flagging mid-treatment.

At nume, every consultation is personally reviewed by a GPhC-registered Independent Prescriber on the day it arrives. Not software, not a triage algorithm, a real clinician whose name is on the prescription. You can meet our clinical team on the site.

Step 2, Verify the supply chain and check for red flags

Mounjaro in the UK comes in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg KwikPens, all manufactured by the company behind Mounjaro and entering the market through licensed UK distributors. The MHRA has been unambiguous: fake weight-loss pens are circulating, sourced mainly through social media and websites that have no pharmacy registration. In October 2025 enforcement teams raided the first illicit UK site producing counterfeit tirzepatide pens in Northampton, the scale of that raid, and the ~20 million doses seized across 2025, tells you what "cheap tirzepatide" outside a licensed pharmacy actually looks like.

Red flags worth noting: a seller offering tirzepatide without a prescription, prices dramatically below the current UK market range (roughly £149–£375 per month depending on dose and provider, as widely reported since the drug company responsible for tirzepatide issued its September 2025 list-price revision), or a "discount code" attached to a medicine listing. Our cost context page explains what a realistic private price includes and why the cheapest listing answers the wrong question for a prescription medicine.

If you encounter a suspect seller, report them at yellowcard.mhra.gov.uk, the MHRA Yellow Card scheme accepts counterfeit and unlicensed-medicine reports from the public.

Step 3, Look at what ongoing clinical support actually covers

The first prescription is not the hard part. Tirzepatide treatment typically starts at 2.5 mg (a dose whose job is settling your system, not producing significant weight loss) and is titrated upward over months by the prescriber, usually in four-week steps. Each step is a clinical decision. Side effects (predominantly gastrointestinal: nausea, loose stools, reduced appetite, occasional reflux) tend to peak around dose increases and ease off, but they need a clinician to help you manage them, not a returns form.

Ask any provider: what happens when I need a dose review? Is there a prescriber I can message? Is aftercare included in the price, or billed separately? The NICE appraisal of tirzepatide (TA1026) is explicit that treatment should sit within a framework of dietary and lifestyle support, that is what a serious provider builds around the prescription, not just the pen.

Timing matters here in a practical sense too. If you place an order on a Thursday afternoon before a bank holiday weekend, does the company have a clear dispatch and delivery policy, or does your pen sit in a warehouse for four days while you are waiting for it? Worth checking before you sign up. At nume, orders placed by 12pm Monday to Friday are dispatched the same day once clinically approved and delivered free by DPD the next working day, tracked, plain packaging.

Step 4, Understand eligibility before you compare providers

No legitimate tirzepatide company can promise you access before a prescriber has assessed your medical history. The licensed eligibility for Mounjaro covers adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related condition (such as hypertension, type 2 diabetes, high cholesterol or obstructive sleep apnoea). Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance. These are starting criteria; a prescriber may find reasons to not recommend treatment even within them, or may identify something in your history that needs addressing first.

The NHS route to tirzepatide follows the phased rollout under NICE TA1026, currently prioritising people with a BMI of 35 or above and multiple weight-related conditions. Many people seeking private treatment either do not meet those NHS thresholds yet or prefer not to wait. A regulated private pharmacy is the legal alternative, provided, again, that a prescriber reviews the full picture. How tirzepatide works as a GLP-1 medicine explains the mechanism if you want the clinical background before deciding, and you can also read more about tirzepatide as a peptide if you want a deeper look at its structure before making your decision.

If you are ready to see whether treatment is suitable for you, check your eligibility with a free consultation.